Improvement of solubility and dissolution properties of ketoconazole by solid dispersions and inclusion complexes

Asian Journal of Pharmaceutical Sciences

Volumn 5, Issue 1, 2010, Pages 1-12

  Balata, Gehan ^a   Mahdi, Mahmoud ^a   Bakera, Rania Abu ^a  

^a Zagazig University   (Egypt)

Author keywords

Antifungal activity; Ketoconazole; Polyvinylpyrrolidone; Topical activity; cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN; DRUG CARRIER; KETOCONAZOLE; POVIDONE; SOLVENT;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; EVAPORATION; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; X RAY POWDER DIFFRACTION;

EID: 77958531109     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. G. Sharma, S. Jain, A. K. Tiwary, et al. Once daily bioadhesive vaginal clotrimazole tablets: design and evaluation. Acta Pharm., 2006, 56: 337-345.
2. P. L. M. Giorgetti. Pharmaceutical preparation containing nimesulide for topical use. European Patent 0853476, 2002.
3. D. Liu, X. Fei, S. Wang, et al. Increasing solubility and dissolution rate of drugs via eutectic mixtures: itraconazole -poloxamer 188 system. Asian J. Pharm. Sci., 2006, 1: 213-221.
4. W. L. Chiou, S. Riegelman. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci., 1971, 60: 1281-1302.
5. J. L. Ford. The current status of solid dispersions. Pharm. Acta Helv., 1986, 61: 69-88.
6. H. Valizadeh, P. Zakeri-Milani, M. B. Jalali, et al. Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev. Ind. Pharm., 2007, 33: 45-56.
7. H. Valizadeh, A. Nokhodchi, N. Qarakhani, et al. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrij 52, Lactose, Sorbitol, dextrin, and Eudragit E100. Drug Dev. Ind. Pharm., 2004, 30: 303-317.
8. D. Xu, S. Wang, J. Jin, et al. Dissolution and absorption researches of curcumin in solid dispersions with the polymers PVP. Asian J. Pharmaco. Pharmacok., 2006, 6: 343-349.
9. D. Q. M. Craig. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm., 2002, 23: 131-144.
10. C. Leuner and J. Dressman. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm., 2000, 50: 47-60.
11. S. Prabhu, D. R. Brocks, G. V. Betageri. Enhancement of dissolution of ethopropazine using solid dispersions prepared with phospholipids and/ or polyethylene glycol. Drug Dev. Ind. Pharm., 2001, 27: 413-418.
12. L. P. Ruan, B. Y. Yu, G. M. Fu, et al. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal., 2005, 38: 457-464.
13. S. Sethia, E. Squillante. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm., 2004, 272: 1-10.
14. N. Yuksel, A. Karatas, Y. Ozkanb, et al. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm., 2003, 56: 453-459.
15. M. Asada, H. Takahashi, H. Okamoto, et al. Theophylline particle design using chitosan by the spray drying. Int. J. Pharm., 2004, 270: 167-174.
16. E. Rodier, H. Lochard, M. Sauceau, et al. A three step supercritical process to improve the dissolution rate of Eflucimibe. Eur. J. Pharm. Sci., 2005, 26: 184-193.
17. K. Uekama. Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull., 2004, 52: 900-915.
18. M. K. Youssef, E. D. El-sayed, M. A. F ouda. Part I: Solid dispersion systems as a means for enhancing rifampicin release from ointments. Clinical evaluation of the proposed formulation. Drug Dev. Ind. Pharm., 1988, 14: 2667-2685.
19. M. Jugi, M. Becirevic-Lacani, A. Kwokal, et al. Influence of cyclodextrin complexation on piroxicam gel formulations. Acta Pharm., 2005, 55: 223-236.
20. A. Doliwa, S. Santoyo, P. Ygartua. Influence of piroxicam: Hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam. Skin Pharmacol. Appl. Skin Physiol., 2001, 14: 97-107.
21. Martindale, 'The Extra Pharmacopeia' The Pharmaceutical Press, London 33th Edition, 2002, 383.
22. M. T. Gayo-Otero, M. B. Pérez-Marcos, J. L. Vila-Jato, et al. Preparation and evaluation of ketoconazole-β- cyclodextrin multi-component complexes. Int. J. Pharm., 1996, 142: 183-187.
23. M. T. Esclusa-Díaz, M. Guimaraens-Méndez, M. B. Perez-Marcos, et al. Characterization and in vitro dissolution behaviour of ketoconazole/β- and 2-hydroxypropyl-β- cyclodextrin inclusion compounds. Int. J. Pharm., 1996, 143: 203-210.
24. F. Taneri, T. Guneri, Z. Aigner, et al. Improvement in the physicochemical properties of ketoconazole through complexation with cyclodextrin derivatives. J. Incl. Phenom., 2003, 44: 257-260.
25. F. Taneri, T. Guneri, Z. Aigner, et al. Influence of cyclodextrin complexation on the physicochemical and biopharmaceutical properties of ketoconazole. J. Incl. Phenom., 2003, 47: 15-23.
26. T. Higuchi, K. A. Connors. Phase solubility techniques, Adv. Anal. Chem. Instrum., 1965, 4: 207-212.
27. G. F. Palmieri, P. Welhrle, S. Martelli. Interactions between Ionidamine and beta- or hydroxypropyl - beta-cyclodextrin. Drug Dev. Ind. Pharm., 1998, 24: 653-660.
28. A. Nokhodchi, R. Talari, H. Valizadeh, et al. An Investigation on the Solid Dispersions of Chlordiazepoxide. Int. J. Biom. Sci., 2007, 3: 211-217.
29. H. M. Patel, B. N. Suhagia, S. A. Shah, et al. Preparation and characterization of etoricoxib-b-cyclodextrin complexes prepared by the kneading method, Acta Pharm. 2007, 57: 351-359.
30. K. A. Khan, C. D. Rhodes. The concept of dissolution efficiency, J. Pharm. Pharmacol., 1975, 27: 48-49.
31. E. Bilensoy, M. A. Rouf, I. Vural, M. Sen, A.A. Hincal. Mucoadhesive thermosensitive, prolonged-release vaginal gel for clotrimazole cyclodextrin complex. AAPS Pharm. Sci. Tech., 2006, 7: Article 38.
32. A. A. Ramadan. Formulation and evaluation of bioadhesive gels containing miconazole nitrate. J. Appl. Sci. Res., 2008, 4: 1052-1065.
33. H. C. Ansel, L. V. Allen. "Pharmaceutical dosage forms and drug delivery systems", 7th edition, Lippincott Willams and Wilkens, Baltimore, 2000, 244-246, 249-251, 253-255, 264-265.
34. Rx List, the internet drug review, Ketoconazole cream user reviews. Copyright© 2009 by RxList Inc.
35. A.W. Baver, W. M. M. Kirby, J. C. Sherris, et al. Antibiotic susceptibility testing by a standardized signal disc method. Am. J. Clin. Pathol., 1966, 45: 493-496.
36. R. D. Connors, E. J. Elder. Using a portfolio of particle growth technologies to enable delivery of drugs with poor water solubility. Drug delivery Tech., 2004, 4: 78-83.
37. J. H. Collett, G. Kesteven. The Solubility of allopurinol in aqueous solutions of polyvinylpyrrolidone. Drug Dev. Ind. Pharm., 1978, 4: 555-568.
38. O. Sammour, A. Zidan, N. Megrab, et al. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS Pharm. Sci. Tech., 2006, 7: Article 55.
39. N. Kaewnopparat, S. Kaewnopparat, A. Jangwang, et al. Increased solubility, dissolution and physicochemical studies of curcumin- polyvinylpyrrolidone K-30 solid dispersions. World Academy Sci., Engineering Tech., 2009, 55: 229-234.
40. J. Shah, S. Vasanti, B. Anroop, et al. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000: preparation and in vitro evaluation. J. Incl. Phenom. Macrocycl. Chem., 2009, 63: 69-75.
41. S. Prajapati, M. C. Gohel, L. D. Patel. Studies to enhance dissolution properties of carbamazepine. Ind. J. Pharm. Sci., 2007, 69: 427-430.
42. G. S. Jadhav, P. R. Vavia, T. D. Nandedkar. Danazol-β- cyclodextrin binary system: A potential application in emergency contraception by the oral route. AAPS Pharm. Sci. Tech., 2007, 8: Article 35.32-32G.
43. V. Tantishaiyakul, N. Kaewnopparat, S. Ingkatawornwong. Properties of solid dispersions of piroxicam in polyvinyl pyrrolidone. Int. J. Pharm., 1999, 181: 143-151.
44. A. S. Narang, A. K. Srivastava. Evaluation of solid dispersions of clofazimine. Drug Dev. Ind. Pharm., 2002, 28: 1001-1013.
45. N. Zerrouk, N. Mennini, M. Francesca, et al. Comparison of the effect of chitosan and polyvinyl pyrrolidone on dissolution properties and analgesic effect of naproxen. Eur. J. Pharm. Biopharm., 2004, 57: 93-99.
46. H. Abdelkader, O. Y. Abdallah, H. S. Salem. Comparison of the effect of tromethamine and polyvinyl pyrrolidone on dissolution properties and analgesic effect of nimesulide. AAPS Pharm. Sci. Tech., 2007, 8: Article 65.
47. H. Malipeddi, A. Agrawal. Comparative evaluation of transdermal formulations of norfloxacin with silver sulfadiazine cream, USP, for burn wound healing property. J. Burns Wounds. 2006, 5: 26-31.
48. H. Van Doorne, E. H. Bosch, C. F. Lerk. Formation arid antimicrobial activity of complexes of β-cyclodextrin and some antimycotic imidazole derivatives. Pharm. World Sci., 1988, 10: 80-85.
49. I. Perdomo-López, A. I. Rodríguez-Pérez, J. M. Yzquierdo-Peiró, et al. Effect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: experimental and computational studies. J. Pharm. Sci., 2002, 91: 2408-2415.